Atlas Global Brands entered into a definitive agreement for the acquisition of 51% of three Israeli medical cannabis pharmacies.
"The addition of these three pharmacies will further expand our geographical coverage with modern designed pharmacies, a patient-focused education platform, and dispensaries tailored to consistent product assortment," said Bernie Yeung, CEO of Atlas Global. "We believe that this acquisition will be beneficial to both patients and our shareholders while continuing to expand our geographical coverage in Israel."
The Proposed Transaction is expected to close in calendar Q4 2023.
For more information:
Atlas Global Brands 
www.atlasglobalbrands.com